It is finally here a large company has applied to US authorities. For the emergency approval of their COVID 19 vaccine. This is after a number of trials. That yielded them an above 94% efficacy. The trials results state that it is especially effective for older people. There are also results which are equally effective on children. Although there are still hurdles to overcome. Such as the requirement to keep the vaccine under very cold temperatures. This allows for the vaccine to be transported and distributed. Without affecting its efficacy rates. However, this has caused a scramble for dry ice. It is hoped if this approval is granted vaccines will be ready by mid to end of December.
The plan is to make it to the vulnerable in society and those working in close contact with affected people.